The U.S. Court of Appeals for the Third Circuit has rejected attempts to revive 315 scuttled cases against Pfizer over claims that its anxiety medication Zoloft caused birth defects.
A three-judge panel of the appeals court ruled June 2 in In re Zoloft to affirm U.S. District Judge Cynthia Rufe of the Eastern District of Pennsylvania’s decision to toss the claims because of insufficient expert support.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
